---
title: "9 Health Care Stocks Moving In Wednesday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290743775.md"
description: "In Wednesday's after-market session, several healthcare stocks moved significantly. Gainers included American Shared Hospital (+14.2%), Greenland Mines (+7.18%), and Lunai Bioworks (+5.83%). Conversely, losers featured ARS Pharmaceuticals (-25.1%), Passage Bio (-18.88%), Taysha Gene Therapies (-10.64%), Aditxt (-10.53%), Rocket Pharmaceuticals (-9.99%), and CytoMed Therapeutics (-9.1%)."
datetime: "2026-06-24T21:05:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290743775.md)
  - [en](https://longbridge.com/en/news/290743775.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290743775.md)
generator: "portal-rs"
---

# 9 Health Care Stocks Moving In Wednesday's After-Market Session

### Gainers

-   **American Shared Hospital** (AMEX:AMS) stock rose 14.2% to $1.61 during Wednesday's after-market session. The market value of their outstanding shares is at $9.7 million.
-   **Greenland Mines** (NASDAQ:GRML) stock moved upwards by 7.18% to $0.24. The company's market cap stands at $34.7 million.
-   **Lunai Bioworks** (NASDAQ:LNAI) shares rose 5.83% to $3.63. The market value of their outstanding shares is at $19.4 million.

### Losers

-   **ARS Pharmaceuticals** (NASDAQ:SPRY) shares declined by 25.1% to $7.9 during Wednesday's after-market session. The company's market cap stands at $1.0 billion.
-   **Passage Bio** (NASDAQ:PASG) stock declined by 18.88% to $4.77. The company's market cap stands at $19.6 million.
-   **Taysha Gene Therapies** (NASDAQ:TSHA) shares fell 10.64% to $6.2. The market value of their outstanding shares is at $1.9 billion.
-   **Aditxt** (NASDAQ:ADTX) shares decreased by 10.53% to $0.01.
-   **Rocket Pharmaceuticals** (NASDAQ:RCKT) stock decreased by 9.99% to $2.97. The market value of their outstanding shares is at $378.9 million.
-   **CytoMed Therapeutics** (NASDAQ:GDTC) shares declined by 9.1% to $0.9. The market value of their outstanding shares is at $11.9 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [SPRY.US](https://longbridge.com/en/quote/SPRY.US.md)
- [TSHA.US](https://longbridge.com/en/quote/TSHA.US.md)
- [ADTX.US](https://longbridge.com/en/quote/ADTX.US.md)
- [AMS.US](https://longbridge.com/en/quote/AMS.US.md)
- [PASG.US](https://longbridge.com/en/quote/PASG.US.md)
- [GRML.US](https://longbridge.com/en/quote/GRML.US.md)
- [GDTC.US](https://longbridge.com/en/quote/GDTC.US.md)
- [RCKT.US](https://longbridge.com/en/quote/RCKT.US.md)
- [LNAI.US](https://longbridge.com/en/quote/LNAI.US.md)
- [GRMLW.US](https://longbridge.com/en/quote/GRMLW.US.md)
- [RENB.US](https://longbridge.com/en/quote/RENB.US.md)
- [RCKTW.US](https://longbridge.com/en/quote/RCKTW.US.md)

## Related News & Research

- [Rocket Pharma to present at Cantor Global Healthcare Conference](https://longbridge.com/en/news/297901994.md)
- [Passage Bio announces $70 million private placement at $1.39 per share, including pre-funded warrants](https://longbridge.com/en/news/297895358.md)
- [Greenland Mines (NASDAQ: GRML) Closes Sarfartoq Rare Earths Acquisition, Advances Project Toward Pre-Feasibility](https://longbridge.com/en/news/297813649.md)
- [Passage Bio Revises Remix Merger to Two-Step Structure, Adds $70 Million Pre-Funded PIPE](https://longbridge.com/en/news/297896887.md)
- [Taysha Gene Therapies highlights TSHA-102 Rett gene therapy path toward BLA submission in corporate presentation](https://longbridge.com/en/news/297550820.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**